Schedule 13D ownership disclosure
Armata Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 04216R102
Event date: 2019-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,107,675
- Percent of class
- 21.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-027380
- Form type
- SC 13D
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- May 21, 2019
- Reporting period
- May 09, 2019
- Description
- Schedule 13D beneficial ownership